FORMULATION AND EVALUATION OF LIQUISOLID COMPACTS OF LORNOXICAM
Objective: Objective of the present investigation was to enhance the solubility and dissolution rate of poorly water-soluble drug lornoxicam using liquisolid technique with comparative determination of in vitro release profile of liquisolid compacts and conventional formulation of lornoxicam.
Methods: Formulation was prepared by a liquisolid technique using different drug concentration in a liquid vehicle and different carrier/coating ratio. Prepared liquisolid compact was evaluated for Fourier transform infrared (FTIR) spectra analysis, differential scanning calorimetry (DSC), X-ray diffraction (P-XRD), scanning electron microscopy (SEM) and in vitro dissolution study.
Results: The result showed that liquisolid compacts of lornoxicam displayed significantly higher drug release rate as compared to pure drug and conventional tablet prepared. The results of both DSC and X-ray crystallography indicated loss of crystallinity of the drug upon formulated into the liquisolid compact.
Conclusion: Dissolution rate of the drug from liquisolid compacts was affected by changing the drug concentration and excipient ratio. The liquisolid technique appeared to be a promising approach for improving the dissolution of poorly soluble drug lornoxicam.
2. Fahmy RH, Kassem MA. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation. Eur J Pharm Biopharm 2008;69:993-1003.
3. Spireas SS. Liquisolid systems and methods of preparing same. United State Patent no 5800834; 1998.
4. Panda S, Varaprasad R, Priyanka K, Swain R. Liquisolid technique: a novel approach for dosage form design. Int J Appl Pharm 2017;9:8-14.
5. Elkordy AA, Tan XN, Ebtessam EA. Spironolactone release from liquisolid formulation prepared with CapryolTM 90, Solutol® HS-15, Kollicoat® SR 30 D as non-volatile liquid vehicles. Eur J Pharm Biopharm 2013;83:203-23.
6. Spireas S, Sadu S. Enhancement of prednisolone dissolution properties using liquisolid compacts. Int J Pharm 1998;166:177-88.
7. Louis D, Soliman II, Tayel SA. Improvement of dissolution properties of carbamazepine through application of the liquisolid tablet technique. Eur J Pharm Biopharm 2008; 69:342-7.
8. Sanjaymitra PV, Ganesh GN. Dissolution and solubility enhancement strategies: current and novel prospectives. J Crit Rev 2018;5:1-10.
9. Banker GS, Anderson NR. Tablets. In: Lachman L, Lieberman HA. editors. The theory and practice of industrial pharmacy. 2nd ed. Noida: India Binding House; 2009. p. 293-45.
10. Noyes AA, Whitney WR. The rate of dissolution of solid substances in their own solutions. J Am Chem Soc 1897;19:930–4.
11. Khan A, Agrawal S. Formulation and evaluation of lumefantrine capsule prepared by using the liquisolid technique. Int J Curr Pharm Res 2018;10:43-50.
12. Hentzschel CM, Alnaief M, Smirnova I, Sakmann A. Enhancement of griseofulvin release from liquisolid compacts. Eur J Pharm Biopharm 2012;80:130-5.
This work is licensed under a Creative Commons Attribution 4.0 International License.